Nasdaq: NFLD), a leading developer of an oxygen-carrying blood substitute
, will present data from its clinical studies to the U.
Nasdaq: SNUS) announced today that it has implemented a restructuring plan to support its strategic decision to refocus on the development of its drug delivery and blood substitute
products, as announced on October 12, 2000.
com) a biopharmaceutical company focused on developing and commercializing the first viable human blood substitute
with their bovine hemoglobin-based solution, HemoTech, provides an update on recent media and financial news.
Northfield Laboratories was founded in 1985 to provide a corporate entity to commercialize the scientific developments of a research team specializing in a hemoglobin-based blood substitute
com), a developmental biopharmaceutical company focused on developing and commercializing the first viable human blood substitute
, has been highlighted in the January 5-11th issue of New Scientist.
This opportunity helps underscore what a significant need the continued development of a safe, non-toxic blood substitute
is for the global marketplace.
In fact, the human-derived hemoglobin oxygen-carrying component is even purified before being added to the blood substitute
Another medical area where the protective powers of trehalose and other sugars may find some use is the preservation of blood substitutes
(SN: 9/26/87, p.
com), a biopharmaceutical company focused on developing and commercializing the first viable human blood substitute
, will present at the EQUITIES 57th Anniversary Spring Conference to be held at the Princeton Club on April 18th, in New York City.
located near Seattle, Washington, is a developer of blood substitute
and drug delivery products.
But perhaps the biggest problem with such hemoglobin-based blood substitutes
is that the hemoglobin must be derived from blood itself.
Scientists have thus been forced to look for alternatives for donated blood, which are called artificial blood substitutes
, artificial haemoglobin or haemoglobin based oxygen carriers (HBOC).
Contract notice: Supplies of medicines, infusion solutions and blood substitutes
, products for particular nutritional uses of pharmaceutical raw materials and packaging, vaccines, surgical and specialist surgical suture materials and containers for blood for the independent public healthcare ministry of the interior in wroclaw.
All efforts to date have essentially focused on the ability of RBCs to carry oxygen, yet no oxygen-carrying blood substitutes
are approved for use by the U.
The Company believes that HemoTech(TM) may possess properties that diminish the intrinsic toxicities which have plagued other attempts at developing blood substitutes
, based upon pre-clinical and initial human clinical trials undertaken outside the U.